Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2753 results

Sort By:

Shared Decision Making to Address Racial Disparities in Oral Anticoagulation in NVAF

Study ID: NCT04956978
Start Date: 2025-12
End Date: 2026-06-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

Patient Decision Support Tool

Sponsor

Duke University

Source: clinicaltrials.gov

Share:
Add to list

Magnetic Resonance Fingerprinting Guided Extended Resection in Glioblastomas

Study ID: NCT06455189
Start Date: 2025-12
End Date: 2029-12-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

114

Intervention / Treatment

Control Group - Standard of care neurosurgical resection

MRF/MRI infiltration guidance for extended resection

Sponsor

Case Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Home Transcranial Direct Current Stimulation (tDCS) to Enhance Functional Recovery

Study ID: NCT07091396
Start Date: 2025-12
End Date: 2031-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

55

Intervention / Treatment

Soterix® tDCS - Home treatment

Cognitive-linguistic therapy

Soterix® tDCS - Lab treatment

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Response-Based Dose Reduction of Linvoseltamab in the Treatment of Relapsed, Refractory, or Triple-Class Relapsed/Refractory Multiple Myeloma

Study ID: NCT07181941
Start Date: 2026-03-01
End Date: 2028-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

Linvoseltamab

Bone Marrow Aspiration

Bone Marrow Biopsy

Computed Tomography

Positron Emission Tomography

Biospecimen Collection

Sponsor

Fred Hutchinson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Cue-Based Vs. Clinician-Driven Feeding in Very Low Birthweight Infants

Study ID: NCT06569186
Start Date: 2026-12
End Date: 2028-10
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

74

Intervention / Treatment

Cue-based feedings

Sponsor

University of Alabama at Birmingham

Source: clinicaltrials.gov

Share:
Add to list

THC + CBD and Memory Study

Study ID: NCT04855526
Start Date: 2025-12-01
End Date: 2026-12-30
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

9

Intervention / Treatment

High THC/No CBD Marihuana

High THC/High CBD Marihuana

No THC/No CBD Marihuana

Sponsor

Hartford Hospital

Source: clinicaltrials.gov

Share:
Add to list

Combined Amivantamab, Carboplatin and Paclitaxel in Unresectable Locally Recurrent or Metastatic Head and Neck Cancer

Study ID: NCT07062354
Start Date: 2025-12
End Date: 2029-10
Study Type

Interventional

Study Phase

Phase2

No. of Participants

50

Intervention / Treatment

Amivantamab Subcutaneous and Co-Formulated with Recombinant Human Hyaluronidase (SC CF)

Sponsor

SWOG Cancer Research Network

Source: clinicaltrials.gov

Share:
Add to list

Studying the Effects of Nicotine Concentration and Flavor on Alcohol Use in Young Adults

Study ID: NCT07095140
Start Date: 2026-01-15
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Ecological Momentary Assessment

Monitoring

Nicotine Oral Pouch

Survey Administration

Sponsor

Ohio State University Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Carcinoma Subtype I (ACC-I)

Study ID: NCT07162480
Start Date: 2026-02-28
End Date: 2031-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

28

Intervention / Treatment

P-Sam

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Phase Ib/II Trial of Regorafenib Plus Lorigerlimab as Neoadjuvant Therapy for Patients With pMMR/MSS, Resectable, Lung-limited Metastatic Colorectal Cancer

Study ID: NCT07137390
Start Date: 2026-02-28
End Date: 2032-12-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

Regorafenib

Lorigerlimab

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list